MarginsXMarginsX
Home › Markets › Health Care › CAI

Caris Life Sciences Inc. (CAI)

CAI trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$21.00
-8.85% on the day
Market cap
$6.0B
Mid cap
Revenue · 2025
$812.0M
+97.0% on 2024
Net income · 2025
-$68.1M
-8.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/2019410/000201941026000016/0002019410-26-000016-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCAI on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2025
SEC CIK0002019410
SEC industry codeServices-Medical Laboratories
Incorporated inTX

Financials · 2025

LineValue
Revenue$812.0M
Net income-$68.1M
Operating income$45.1M
Net margin-8.4%
Operating margin5.6%
Revenue growth+97.0%
Cash$796.3M
Total assets$1.1B
P/E (computed)Net income was not positive
P/S (computed)7.4×

Warning signs

Cash runway
Cash-flow positive
$819.9M cash at March 31, 2026
Share count, 1 year
+1.6%
2025-11-03 to 2026-11-02
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$27.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$819.9M cash; operating cash flow $21.0M a quarter.Report 2026-09-30
Shares outstanding286,784,504 (2026-11-02); 282,146,923 a year earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.6M, sold $28.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$275.4M$15.3M-$22.2MNot filed$393.0M$1.0B10-Q 2026-11-04
Q2 2026
2026-06-30
$263.7M-$637K$28.5MNot filed$392.7M$989.6M10-Q 2026-08-05
Q1 2026
2026-03-31
$216.2M-$510K$32.9M$819.9M$381.1M$907.3M10-Q 2026-05-08
Q4 2025
2025-12-31
$292.9M$82.0M$44.8M$796.3M$378.4M$812.0M10-K 2026-03-03
Q3 2025
2025-09-30
$216.8M$24.3M$62.4M$753.2M$375.9M$649.1M10-Q 2026-11-04
Q2 2025
2025-06-30
$181.4M-$71.8M$7.3M$718.9M$373.4M$533.8M10-Q 2026-08-05
Q1 2025
2025-03-31
$120.9M-$102.6M-$31.3M$31.2MNo debt tags$452.5M10-Q 2026-05-08
Q4 2024
2024-12-31
$129.9M-$36.9M-$38.9M$64.0M$373.1M$412.3M10-K 2026-03-03

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-06-20
Latest annual report10-K2026-03-03
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 134 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-8.7%
1 month-22.0%
3 months+3.9%
Year to date-14.6%
1 year-5.2%
From 52-week high-36.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
RDNTRadNet Inc.$76.89+0.61%$6.1B
CONConcentra Group Holdings Parent Inc.$43.44+2.09%$5.5B
GRALGRAIL Inc. Common Stock$105.60-8.88%$4.7B
BLLNBillionToOne Inc.$96.31-8.41%$4.6B
CDNACareDx Inc.$73.72-5.34%$3.9B
HSICHenry Schein Inc.$84.96-1.46%$9.4B
OSCROscar Health Inc.$31.33+0.90%$9.7B
ACHCAcadia Healthcare Company Inc.$38.70+2.44%$3.6B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier